Book Cover
Home  |   Healthcare   |  Blood Pressure Monitoring Devices Market

Blood Pressure Monitoring Devices Market Size, Share, Growth, and Industry Analysis, By Type (Aneroid BP Monitors,Digital BP Monitors,Blood Pressure Instrument Accessories,Ambulatory BP Monitors), By Application (Hospitals,Clinics,Other End Users), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Blood Pressure Monitoring Devices Market Overview

The global Blood Pressure Monitoring Devices Market size is projected to grow from USD 1577.96 million in 2026 to USD 1622.15 million in 2027, reaching USD 2017.72 million by 2035, expanding at a CAGR of 2.8% during the forecast period.

The global Blood Pressure Monitoring Devices Market is characterized by sales of over 300 million units by leading manufacturers in a single calendar year. For instance, one company reported that its global sales of blood pressure monitors surpassed 300,000,000 units, securing the largest market share globally. In a given sample year, North America accounted for approximately 38.3 % of the total units market share in 2024. Asia-Pacific, Europe, Latin America and Middle East & Africa together made up the remaining ~61.7 %. The market consists of device types such as digital monitors, ambulatory monitors, aneroid monitors, and accessories.

In the United States, the Blood Pressure Monitoring Devices Market is a critical segment of remote patient monitoring and home health. As of 2023, the U.S. BP monitoring market size was estimated at USD 1.64 billion in device value terms. In 2024, the U.S. market included a dominant share of the sphygmomanometer (aneroid and manual) segment, which held the largest product portion. Ambulatory BP monitors are the fastest-growing in the U.S. by unit deployment. The U.S. is also home to key players such as Omron and Hill-Rom. The U.S. market accounts for roughly 39 % of the North American segment in many analyses.

Global Blood Pressure Monitoring Devices Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: 45 % of global hypertensive patients reside in low- and middle-income countries, driving device demand
  • Major Market Restraint: 22 % of devices fail calibration accuracy over time in field deployments
  • Emerging Trends: 30 % growth in cuffless wearable BP devices adoption in 2024
  • Regional Leadership: North America holds ~38 % share of the global unit installations
  • Competitive Landscape: Top 2 firms account for approximately 26 % of global device shipments
  • Market Segmentation: Digital monitors represent ~55 % of total units in 2024
  • Recent Development: 28 % of new product launches in 2024 were IoT-enabled BP devices

The Blood Pressure Monitoring Devices Market Trends reflect rapid technological convergence and product innovation. In 2024, digital blood pressure monitors accounted for ~55 % of global unit shipments, making them the largest segment by type. Meanwhile, ambulatory blood pressure monitors (ABPM) exhibited strong traction: they captured ~15 % of new hospital and clinical purchases in 2024. Another trend: cuffless wearable BP monitors progressed from ~2 % share in 2022 to ~10 % by mid-2025. Remote patient monitoring integration is now in ~40 % of advanced clinical settings, using Bluetooth, Wi-Fi and cloud data. In developed regions, ~70 % of hypertension patients use home BP monitoring devices monthly. Use of automatic and smart BP monitors rose by ~25 % year-on-year. Telehealth programs in certain markets increased device prescriptions by ~35 %. In 2024 alone, ~28 % of new BP device launches were IoT driven, with real-time alerts and AI analytics. Adoption of connected BP systems in hospital settings increased by ~18 % in 2024. The Blood Pressure Monitoring Devices Market Report thus underscores that connected, wearable, and ambulatory modalities are key trend vectors in the Blood Pressure Monitoring Devices Market Forecast context.

Blood Pressure Monitoring Devices Market Dynamics

DRIVER

"Rising prevalence of hypertension and cardiovascular disease"

Hypertension affects over 1.13 billion people globally. In many developed nations, ~45 % of adults have elevated blood pressure. In the U.S., nearly half of adults have high blood pressure per national health surveys. These high prevalence figures drive demand for regular and continuous monitoring. Aging populations exacerbate the trend: in several major economies, >20 % of populations are older than 65 years. In China and India combined, over 600 million individuals are estimated to have hypertension. 

RESTRAINT

"Accuracy issues and calibration concerns"

One major challenge is device precision. In field studies, ~22 % of BP monitors lose calibration accuracy within 12 months. Up to 18 % of home digital monitors show ±5 mmHg deviations versus clinical standards. Many devices must be recalibrated every 6–12 months—~30 % of users fail to maintain calibration, resulting in measurement errors. In developing regions, ~25 % of devices are subject to inaccurate cuff sizes or misuse. 

OPPORTUNITY

"Growth in smart and cuffless blood pressure devices"

Cuffless wearable blood pressure monitoring is expanding: in 2024 unit shipments grew ~35 % over 2023. In 2024, ~10 % of new BP monitor models were cuffless or optical sensors. Integration with smartphone apps saw ~28 % of users opting for connected data dashboards. In markets like Japan, ~20 % of hypertensive patients now try wearable BP sensors. In the U.S., telehealth programs integrated wearable BP devices in ~12 % of remote monitoring protocols in 2024. 

CHALLENGE

"Regulatory hurdles and reimbursement barriers"

Obtaining approval from major regulatory authorities is nontrivial: in 2024, ~15 % of new BP monitoring device submissions were delayed or rejected. Reimbursement constraints also hamper uptake—only ~55 % of U.S. insurers reimburse home BP equipment. In many emerging markets, device costs exceed average per capita health device budgets in ~25 % of regions, limiting deployment. 

Blood Pressure Monitoring Devices Market Segmentation

Global Blood Pressure Monitoring Devices Market Size, 2035 (USD Million)

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

The Blood Pressure Monitoring Devices Market Segmentation is defined by type and application. By type, categories include Aneroid (manual), Digital (automatic), Ambulatory BP Monitors, and Accessories (cuffs, transducers). The digital segment held ~55 % of global units in 2024; aneroid accounted for ~20 %; ambulatory ~15 %; accessories ~10 %. By application, end-users include hospitals, clinics, and other end users (homecare, pharmacies). Hospitals consumed ~45 % of installed devices in 2024, clinics ~30 %, and other end users ~25 %. These divisions are fundamental in any Blood Pressure Monitoring Devices Market Share analysis.

BY TYPE

Aneroid BP Monitors: Aneroid (manual) sphygmomanometers remain relevant in many clinical settings, especially in operating rooms and backup use. In 2024, aneroid monitors represented ~20 % of device shipments by units. Their advantages: low power, mechanical reliability, affordability. They are widely used in training institutions, with ~35 % of medical schools still teaching use of aneroid devices. In emerging countries, ~40 % of primary health centers continue to rely on aneroid monitors due to cost constraints.

The Aneroid BP Monitors segment holds a significant share, estimated at USD 312.45 million in 2025, expected to reach USD 388.71 million by 2034, growing at a CAGR of 2.5%, supported by affordability and clinical reliability.

Top 5 Major Dominant Countries in the Aneroid BP Monitors Segment

  • United States: The U.S. market size is USD 96.23 million in 2025, with 31% share and a CAGR of 2.7%, driven by strong hospital adoption and physician preference for manual monitoring accuracy.
  • Germany: Estimated at USD 42.11 million in 2025, holding 13.5% share with a CAGR of 2.4%, supported by widespread clinical usage and robust healthcare infrastructure.
  • Japan: Market size reaches USD 36.57 million in 2025, with 11.7% share and a CAGR of 2.3%, boosted by aging population and home healthcare adoption.
  • United Kingdom: Valued at USD 28.39 million in 2025, with 9.1% share and 2.2% CAGR, supported by NHS initiatives promoting preventive hypertension management.
  • India: Holds USD 22.74 million in 2025, 7.3% share, and a CAGR of 3.0%, driven by growing awareness and availability of low-cost manual BP devices.

Digital BP Monitors: Digital (automatic) monitors dominate the market, with ~55 % of units shipped in 2024. Among those, upper-arm automatic monitors make up ~65 % of digital shipments, while wrist monitors ~25 %, and finger monitors ~10 %. Digital devices offer ease of use, memory storage, connectivity.

The Digital BP Monitors segment dominates the market, valued at USD 754.92 million in 2025, projected to reach USD 1012.15 million by 2034, growing at a CAGR of 3.3%, driven by home-use demand and smart connectivity.

Top 5 Major Dominant Countries in the Digital BP Monitors Segment

  • United States: Estimated at USD 241.85 million in 2025, 32% share, with a 3.5% CAGR, driven by advanced home-use monitoring adoption and wearable tech integration.
  • China: Valued at USD 165.27 million in 2025, 21.9% share, growing at 3.8% CAGR, owing to large population and expanding digital healthcare infrastructure.
  • Germany: Holds USD 89.14 million in 2025, 11.8% share, with 3.1% CAGR, supported by high usage of telehealth and smart monitoring devices.
  • Japan: Market size is USD 78.63 million in 2025, 10.4% share, at a CAGR of 3.0%, due to aging demographics and home monitoring convenience.
  • India: Estimated at USD 61.32 million in 2025, 8.1% share, growing at 3.9% CAGR, driven by digitalization of healthcare and growing middle-class awareness.

Ambulatory BP Monitors: Ambulatory blood pressure monitors (ABPM) capture ~15 % of the device installations in clinical settings in 2024. ABPM systems record readings at fixed intervals over 24 hours, capturing night-time, white-coat, and masked hypertension. In hospital cardiology departments, ~25 % of hypertension diagnosis includes an ABPM component.

The Ambulatory BP Monitors segment is estimated at USD 190.74 million in 2025, projected to reach USD 224.46 million by 2034, growing at a CAGR of 1.9%, attributed to its clinical precision and diagnostic utility.

Top 5 Major Dominant Countries in the Ambulatory BP Monitors Segment

  • United States: Valued at USD 59.03 million in 2025, 30.9% share, with 2.0% CAGR, driven by demand for continuous 24-hour blood pressure tracking.
  • Germany: Market size USD 28.96 million in 2025, 15.2% share, with 1.8% CAGR, supported by hospital-based diagnostic protocols.
  • United Kingdom: Holds USD 24.81 million in 2025, 13% share, at 1.9% CAGR, due to increased adoption in outpatient clinics.
  • Japan: Estimated at USD 21.37 million in 2025, 11.2% share, with 1.7% CAGR, fueled by elderly monitoring needs.
  • China: Valued at USD 18.29 million in 2025, 9.6% share, growing at 2.1% CAGR, driven by expanding diagnostic infrastructure.

Blood Pressure Instrument Accessories: Accessories—such as cuffs, inflation bulbs, hoses, transducers—account for ~10 % of unit sales in 2024 (in terms of count of accessories). Replacement cuffs contribute ~60 % of accessory sales volume owing to wear and size changes. Transducer modules and calibration modules make up ~25 %, and miscellaneous connectors ~15 %. and miscellaneous connectors ~15 %.

The Blood Pressure Instrument Accessories segment is valued at USD 276.87 million in 2025, projected to reach USD 337.44 million by 2034, growing at a CAGR of 2.3%, supported by recurring demand for cuffs and components.

Top 5 Major Dominant Countries in the Blood Pressure Instrument Accessories Segment

  • United States: Market size is USD 83.56 million in 2025, 30.1% share, with 2.4% CAGR, driven by continuous replacement and hospital-grade accessories.
  • Germany: Valued at USD 38.62 million in 2025, 13.9% share, with 2.2% CAGR, supported by stringent clinical standards and regular maintenance cycles.
  • Japan: Estimated at USD 33.71 million in 2025, 12.2% share, with 2.3% CAGR, due to stable device replacement demand.
  • France: Holds USD 27.48 million in 2025, 9.9% share, with 2.1% CAGR, influenced by expanding healthcare facilities.
  • China: Market size is USD 22.93 million in 2025, 8.3% share, at a 2.7% CAGR, driven by growing domestic device manufacturing.

BY APPLICATION

Hospitals: Hospitals represented ~45 % of installed devices in 2024. Large tertiary hospitals order bulk digital and ambulatory systems—~60 % of hospital procurement is digital, ~20 % ambulatory, ~15 % aneroid, ~5 % accessories. High volumes justify service contracts: ~30 % of hospitals opt for multi-year maintenance of BP monitoring systems.

The Hospitals segment represents the largest share, estimated at USD 735.21 million in 2025, expected to grow at a CAGR of 2.9%, owing to advanced infrastructure and constant patient monitoring requirements.

Top 5 Major Dominant Countries in the Hospitals Application

  • United States: USD 231.27 million in 2025, 31.5% share, and 3.0% CAGR, driven by advanced hospital systems and chronic disease management programs.
  • Germany: USD 88.91 million in 2025, 12.1% share, with 2.8% CAGR, due to standardized hospital equipment requirements.
  • Japan: USD 72.34 million in 2025, 9.8% share, growing at 2.6% CAGR, owing to comprehensive inpatient care systems.
  • China: USD 65.18 million in 2025, 8.9% share, with 3.2% CAGR, driven by increasing hospital infrastructure investments.
  • India: USD 56.49 million in 2025, 7.7% share, with 3.3% CAGR, fueled by expanding healthcare access.

Clinics: Clinics (including outpatient and specialty clinics) captured ~30 % share of device installations. Clinics tend to prefer compact digital monitors (upper arm and wrist), ~70 % of their devices digital, ~20 % accessory replacements, ~10 % ambulatory or hybrid.

The Clinics segment accounts for USD 512.48 million in 2025, projected to expand at a CAGR of 2.7%, supported by preventive healthcare and outpatient diagnostic growth.

Top 5 Major Dominant Countries in the Clinics Application

  • United States: USD 148.63 million in 2025, 29% share, 2.9% CAGR, driven by widespread primary care facilities.
  • Germany: USD 69.14 million in 2025, 13.5% share, 2.6% CAGR, with increased adoption of standardized diagnostic devices.
  • Japan: USD 55.23 million in 2025, 10.8% share, 2.4% CAGR, supported by extensive private clinic networks.
  • China: USD 47.11 million in 2025, 9.2% share, 2.8% CAGR, boosted by rising outpatient care centers.
  • United Kingdom: USD 42.97 million in 2025, 8.4% share, 2.5% CAGR, encouraged by NHS preventive health programs.

Other End Users: Other end users include homecare, pharmacies, and remote monitoring programs, accounting for ~25 % of unit shipments. Home care patients acquired ~60 % digital monitors and ~10 % wearable/cuffless in 2024; ~30 % were accessory replacements.

The Other End Users segment, including homecare and ambulatory services, is valued at USD 287.29 million in 2025, growing at a CAGR of 2.5%, driven by self-monitoring and telehealth expansion.

Top 5 Major Dominant Countries in the Other End Users Application

  • United States: USD 87.45 million in 2025, 30.4% share, 2.6% CAGR, led by rapid adoption of home monitoring systems.
  • China: USD 53.29 million in 2025, 18.5% share, 2.7% CAGR, supported by consumer electronics integration.
  • Japan: USD 42.11 million in 2025, 14.7% share, 2.3% CAGR, driven by elderly home monitoring programs.
  • India: USD 36.18 million in 2025, 12.6% share, 2.8% CAGR, owing to affordable device availability.
  • Germany: USD 28.13 million in 2025, 9.8% share, 2.4% CAGR, supported by telehealth advancements.

Blood Pressure Monitoring Devices Market Regional Outlook

Global Blood Pressure Monitoring Devices Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

NORTH AMERICA

The North America Blood Pressure Monitoring Devices Market represents the largest share of the global landscape, accounting for approximately 38.3 % of total unit installations in 2024. Within this region, the United States remains the dominant contributor, holding nearly 90 % of North America’s market volume. In 2023, the U.S. market value for blood pressure monitoring devices reached around USD 1.64 billion, primarily driven by the high prevalence of hypertension affecting over 120 million adults. 

The North America Blood Pressure Monitoring Devices Market is estimated at USD 594.67 million in 2025, projected to reach USD 756.84 million by 2034, growing at a CAGR of 2.9%.

North America - Major Dominant Countries in the Blood Pressure Monitoring Devices Market

  • United States: Market size is USD 489.76 million in 2025, with an 82.3% share and a 3.0% CAGR, driven by digital healthcare expansion and widespread self-monitoring device usage.
  • Canada: Valued at USD 58.92 million in 2025, holding a 9.9% share and 2.8% CAGR, supported by national health reforms and preventive cardiac care initiatives.
  • Mexico: USD 29.63 million in 2025, with a 4.9% share and 2.7% CAGR, driven by healthcare modernization and affordable BP monitoring solutions.
  • Cuba: Estimated at USD 9.87 million in 2025, representing 1.6% share and 2.4% CAGR, with strong government-backed healthcare programs.
  • Panama: Market size of USD 6.49 million in 2025, with 1.1% share and 2.5% CAGR, driven by increased adoption of imported medical monitoring devices.

EUROPE

In Europe, the BP monitoring devices market accounted for ~29.3 % of global installations in 2024. Countries like Germany, the UK, and France are leading. Germany alone sees > 60 % of hypertensive patients using home BP monitoring devices, thanks to full reimbursement.

The Europe Blood Pressure Monitoring Devices Market is valued at USD 436.28 million in 2025, projected to reach USD 540.18 million by 2034, at a CAGR of 2.6%.

Europe - Major Dominant Countries in the Blood Pressure Monitoring Devices Market

  • Germany: Estimated at USD 126.15 million in 2025, with a 28.9% share and a 2.7% CAGR, driven by robust hospital infrastructure and adoption of advanced diagnostic systems.
  • United Kingdom: Market size is USD 89.34 million in 2025, 20.5% share, growing at 2.5% CAGR, boosted by public health initiatives and hypertension screening programs.
  • France: Valued at USD 73.49 million in 2025, 16.8% share, with 2.4% CAGR, supported by expanding home healthcare usage.
  • Italy: USD 65.22 million in 2025, holding 14.9% share and 2.5% CAGR, driven by rising awareness of cardiovascular health.
  • Spain: Market size of USD 54.08 million in 2025, representing 12.4% share and 2.6% CAGR, influenced by increasing adoption of telemedicine tools.

ASIA-PACIFIC

Asia-Pacific is the fastest growth region by units. In 2024, the region held ~23 % of the global market share (unit basis). China and India together account for > 600 million hypertensive individuals. In China, the BP monitor market value was ~USD 512.45 million in 2024; wearable and connected devices rose ~30 % year on year. 

The Asia Blood Pressure Monitoring Devices Market is estimated at USD 358.19 million in 2025, projected to reach USD 475.76 million by 2034, growing at a CAGR of 3.2%.

Asia - Major Dominant Countries in the Blood Pressure Monitoring Devices Market

  • China: USD 142.57 million in 2025, 39.8% share, with a 3.4% CAGR, supported by domestic production capacity and growing healthcare infrastructure.
  • Japan: Estimated at USD 108.32 million in 2025, 30.2% share, and 3.1% CAGR, driven by a high geriatric population and adoption of home-use monitoring devices.
  • India: Market size of USD 64.29 million in 2025, 18% share, growing at 3.5% CAGR, supported by affordable device penetration and healthcare digitalization.
  • South Korea: Valued at USD 25.68 million in 2025, with 7.2% share and 3.0% CAGR, driven by wearable technology and preventive health trends.
  • Indonesia: USD 17.33 million in 2025, 4.8% share, and 3.2% CAGR, boosted by growing urban healthcare investments and hypertension awareness.

MIDDLE EAST & AFRICA

In Middle East & Africa, the BP monitoring devices market is nascent but growing. In 2024, the region accounted for ~2 % of global volume. In GCC nations (e.g., UAE, Saudi Arabia), device adoption rates exceed ~20 % in urban populations. 

The Middle East and Africa Blood Pressure Monitoring Devices Market is valued at USD 145.84 million in 2025, projected to reach USD 190.71 million by 2034, growing at a CAGR of 2.5%.

Middle East and Africa - Major Dominant Countries in the Blood Pressure Monitoring Devices Market

  • Saudi Arabia: Market size is USD 39.16 million in 2025, 26.9% share, with a 2.6% CAGR, driven by modern hospital networks and preventive healthcare campaigns.
  • United Arab Emirates: Valued at USD 28.67 million in 2025, with a 19.7% share and 2.7% CAGR, due to strong focus on medical innovation and smart device integration.
  • South Africa: USD 25.33 million in 2025, 17.4% share, with a 2.4% CAGR, supported by growing hypertension management programs.
  • Egypt: Estimated at USD 21.79 million in 2025, holding a 14.9% share and 2.5% CAGR, driven by public healthcare improvement initiatives.
  • Israel: Market size of USD 17.16 million in 2025, 11.8% share, and 2.3% CAGR, supported by advanced digital health technology development.

List of Top Blood Pressure Monitoring Devices Companies

  • A&D Company
  • Contec Medical Systems
  • General Electric Company
  • Halma plc
  • Hill-Rom Holdings
  • Koninklijke Philips
  • Masimo Corporation
  • Nihon Kohden Corporation
  • Omron Corporation
  • Smiths Group Plc.

Omron Healthcare: sold over 300 million units cumulatively, holds the largest global market share in home and clinical BP monitors.

Hill-Rom Holdings: one of top players in institutional BP monitoring devices, with significant share in clinical and hospital BP systems.

Investment Analysis and Opportunities

In the Blood Pressure Monitoring Devices Market Report context, investment flows are trending toward digital, connected, and wearable innovations. In 2024, ~28 % of new BP device launches included IoT connectivity or cloud capabilities. Venture capital funding for remote BP startups increased ~45 % compared to 2023. Strategic partnerships between device makers and telehealth platforms rose by ~30 % in 2024. 

New Product Development

Innovation in the Blood Pressure Monitoring Devices Market is accelerating. In 2024, ~28 % of new product launches were IoT or AI-enabled. One manufacturer introduced a wrist-based BP monitor with integrated ECG tracking in early 2025, targeting high-risk cardiac patients. Another firm secured FDA clearance in 2025 for a hybrid smartwatch with cuffless BP monitoring capabilities, combining optical sensors with calibration for better accuracy. Wearable monitors advanced from ~2 % share in 2022 to ~10 % by 2024. 

Five Recent Developments

  • In March 2025, Omron introduced a wrist-based BP monitor with ECG tracking and real-time alerts, representing ~28 % of its new model launches.
  • In February 2025, Withings won clearance to launch a hybrid smartwatch with cuffless blood pressure monitoring capabilities, part of ~10 % of 2025 wearable device introductions.
  • In 2025, Omron announced construction of its first Indian manufacturing plant in Chennai, aiming to boost local production.
  • In 2024, U.S. telehealth reimbursement guidelines expanded to cover BP devices, fueling ~40 % increase in remote BP monitoring programs.
  • In 2024, a major healthcare system in Europe deployed connected BP monitors across ~100 hospitals covering ~1 million patients, with real-time data aggregation.

Report Coverage of Blood Pressure Monitoring Devices Market

The Blood Pressure Monitoring Devices Market Report covers device types (aneroid, digital monitors, ambulatory monitors, accessories) and applications (hospitals, clinics, home/other end users). It provides unit shipments, market share by region, product innovation pipelines, competitive landscape, product pricing, and adoption trends. The Report includes ~210 tables and ~110 figures on unit volumes, device mix, installations by region, and replacement cycles. 

Blood Pressure Monitoring Devices Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 1577.96 Million in 2026

Market Size Value By

USD 2017.72 Million by 2035

Growth Rate

CAGR of 2.8% from 2026 - 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Aneroid BP Monitors
  • Digital BP Monitors
  • Blood Pressure Instrument Accessories
  • Ambulatory BP Monitors

By Application :

  • Hospitals
  • Clinics
  • Other End Users

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Blood Pressure Monitoring Devices Market is expected to reach USD 2017.72 Million by 2035.

The Blood Pressure Monitoring Devices Market is expected to exhibit a CAGR of 2.8% by 2035.

A&D Company,Contec Medical Systems,General Electric Company,Halma plc,Hill-Rom Holdings,Koninklijke Philips,Masimo Corporation,Nihon Kohden Corporation,Omron Corporation,Smiths Group Plc..

In 2026, the Blood Pressure Monitoring Devices Market value stood at USD 1577.96 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified